IL13 and triple-negative breast carcinoma: In mouse tumor models, innate lymphoid cells promoted triple-negative breast cancer (TNBC) lung metastasis through the IL-13 axis, whereas IL-13 blockade delayed pro-tumor TIME establishment [46, 47].